|
A randomized phase II study with ilixadencel, a cell-based immune primer, plus sunitinib versus sunitinib alone in synchronous metastatic renal cell carcinoma. |
|
|
Honoraria - Bristol-Myers Squibb; Ipsen; Pfizer |
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Biotech Funds |
Consulting or Advisory Role - Astellas Pharma |
|
|
|
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pfizer; Roche; Sanofi; SERVIER |
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Research Funding - Immunicum |
Travel, Accommodations, Expenses - Lekam |
|
|
Honoraria - Combat Medical |
Consulting or Advisory Role - Combat Medical |
Travel, Accommodations, Expenses - Combat Medical; Infinity Pharmaceuticals; Ipsen |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer; Takeda |
|
|
Travel, Accommodations, Expenses - Ferring |
(OPTIONAL) Uncompensated Relationships - Astellas Pharma |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA Pharma |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Ipsen; Janssen; PAREXEL |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Novartis; Roche |
Consulting or Advisory Role - Astellas Pharma; Bayer Schering Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; EUSA Pharma; Ipsen; Janssen Oncology; Merck KGaA; Merck KGaA; Pfizer; Roche; Rovi; Sanofi; Shenzen Techdow Pharma |
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Ipsen; Janssen Oncology; LEO Pharma; Menarini; Novartis; Novartis; Pfizer; Roche; Rovi; Sanofi |
Travel, Accommodations, Expenses - Astellas Pharma; Bayer Schering Pharma; Bristol-Myers Squibb; Eisai; Janssen; Pfizer; Pierre Fabre; Roche |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Pfizer |
|
|
No Relationships to Disclose |
|
|
|
|
Stock and Other Ownership Interests - Immunicum |
Travel, Accommodations, Expenses - Immunicum |
|
|
Consulting or Advisory Role - Ipsen; Janssen; Novartis |
Speakers' Bureau - Bristol-Myers Squibb; Ipsen; Pfizer |